[HTML][HTML] Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease

A Chait, LJ Den Hartigh - Frontiers in cardiovascular medicine, 2020 - frontiersin.org
Adipose tissue plays essential roles in maintaining lipid and glucose homeostasis. To date
several types of adipose tissue have been identified, namely white, brown, and beige, that …

FGF21: an emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases

EJ Tillman, T Rolph - Frontiers in endocrinology, 2020 - frontiersin.org
The rising global prevalence of obesity, metabolic syndrome, and type 2 diabetes has driven
a sharp increase in non-alcoholic fatty liver disease (NAFLD), characterized by excessive fat …

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

C Degirolamo, C Sabbà, A Moschetta - Nature reviews Drug discovery, 2016 - nature.com
The endocrine fibroblast growth factors (FGFs), FGF19, FGF21 and FGF23, are critical for
maintaining whole-body homeostasis, with roles in bile acid, glucose and lipid metabolism …

Fibroblast growth factor 21—metabolic role in mice and men

H Staiger, M Keuper, L Berti… - Endocrine …, 2017 - academic.oup.com
Since its identification in 2000, the interest of scientists in the hepatokine fibroblast growth
factor (FGF) 21 has tremendously grown, and still remains high, due to a wealth of very …

FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study

A Suomalainen, JM Elo, KH Pietiläinen… - The Lancet …, 2011 - thelancet.com
Background Muscle biopsy is the gold standard for diagnosis of mitochondrial disorders
because of the lack of sensitive biomarkers in serum. Fibroblast growth factor 21 (FGF-21) is …

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice

Z Lin, X Pan, F Wu, D Ye, Y Zhang, Y Wang, L **… - Circulation, 2015 - Am Heart Assoc
Background—Fibroblast growth factor 21 (FGF21) is a metabolic hormone with pleiotropic
effects on glucose and lipid metabolism and insulin sensitivity. It acts as a key downstream …

FGF family: from drug development to clinical application

Q Hui, Z **, X Li, C Liu, X Wang - International journal of molecular …, 2018 - mdpi.com
Fibroblast growth factor (FGF) belongs to a large family of growth factors. FGFs use
paracrine or endocrine signaling to mediate a myriad of biological and pathophysiological …

FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders

JM Lehtonen, S Forsström, E Bottani, C Viscomi… - Neurology, 2016 - AAN Enterprises
Objective: To validate new mitochondrial myopathy serum biomarkers for diagnostic use.
Methods: We analyzed serum FGF21 (S-FGF21) and GDF15 from patients with (1) …

Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives

YC Woo, A Xu, Y Wang, KSL Lam - Clinical endocrinology, 2013 - Wiley Online Library
Summary Fibroblast growth factor 21 (FGF 21), a metabolic hormone predominantly
produced by the liver, is also expressed in adipocytes and the pancreas. It regulates glucose …

FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases

N Itoh - Frontiers in endocrinology, 2014 - frontiersin.org
Fibroblast growth factor (FGF) family members are mostly secreted as signaling proteins with
diverse functions in development and metabolism. FGF21 is a unique FGF with metabolic …